Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Regeneron Pharmaceuticals, Inc. (Symbol: REGN), where a total of 4,413 contracts have traded so far, representing approximately 441,300 underlying shares. That amounts to about 70.6% of REGN's average daily trading volume over the past month of 625,235 shares. Especially high volume was seen for the $355 strike put option expiring August 16, 2019, with 362 contracts trading so far today, representing approximately 36,200 underlying shares of REGN. Below is a chart showing REGN's trailing twelve month trading history, with the $355 strike highlighted in orange:

Cimarex Energy Co (Symbol: XEC) saw options trading volume of 10,257 contracts, representing approximately 1.0 million underlying shares or approximately 70% of XEC's average daily trading volume over the past month, of 1.5 million shares. Particularly high volume was seen for the $115 strike call option expiring December 20, 2019, with 8,803 contracts trading so far today, representing approximately 880,300 underlying shares of XEC. Below is a chart showing XEC's trailing twelve month trading history, with the $115 strike highlighted in orange:

And International Flavors & Fragrances Inc. (Symbol: IFF) saw options trading volume of 5,051 contracts, representing approximately 505,100 underlying shares or approximately 48.4% of IFF's average daily trading volume over the past month, of 1.0 million shares. Especially high volume was seen for the $115 strike put option expiring May 17, 2019, with 2,501 contracts trading so far today, representing approximately 250,100 underlying shares of IFF. Below is a chart showing IFF's trailing twelve month trading history, with the $115 strike highlighted in orange:

For the various different available expirations for REGN options, XEC options, or IFF options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 ยป
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.